MetaCap

GlucoTrack (GCTK) vs MiniMed Group (MMEDV)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Relative performance

GCTK-3.48%MMEDV+2.07%
+2%-1%-4%
Oct 7, 20261 yearOct 8, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

GCTK versus MMEDV key metrics
MetricGCTKMMEDV
Share price$1.03$19.50
Market cap$1.05M—
1-day change-7.21%-1.02%
EPS (TTM)$-123.15—
Dividend yield0.00%0.00%
Annual dividend$0.00—
52-week high$123.75$20.00
52-week low$1.01$18.50
Distance from 52-week high-99.17%-2.50%
Average volume2.06M2.40K
Shares outstanding1.02M—
Employees15—
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About GlucoTrack

GCTK stock →

GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.

Health Care · Medical/Dental Instruments · 15 employees

GCTK vs MMEDV FAQ

Are GlucoTrack and MiniMed Group in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons